WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using <italic style="font-style: italic">Actinidia </italic>roots

WU Yichao; SONG Lianying; YAO Yaoyao; LU Dongdong; ZHANG Yaosheng

doi:10.16025/j.1674-1307.2025.01.016

您当前的位置：

首页 >

文章列表页 >

WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using Actinidia roots

更新时间：2025-01-24

- WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using Actinidia roots
- Beijing Journal of Traditional Chinese Medicine Vol. 44, Issue 1, Pages: 80-83(2025)
- 作者机构：
  
  1.北京中医药大学东直门医院泌尿外科，北京 100700
  2.北京中医药大学东直门医院影像科，北京 100700
  3.北京中医药大学东直门医院脑病科，北京 100700
  4.北京市中西医肿瘤微创医学中心，北京 101100
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2025.01.016
  CLC：
- Published：25 January 2025，
  
  Received：01 April 2024，
- 稿件说明：
移动端阅览
WU YICHAO, SONG LIANYING, YAO YAOYAO, et al. WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using Actinidia roots. [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 80-83.
DOI：

WU YICHAO, SONG LIANYING, YAO YAOYAO, et al. WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using Actinidia roots. [J]. Beijing journal of traditional chinese medicine, 2025, 44(1): 80-83. DOI： 10.16025/j.1674-1307.2025.01.016.

摘要

颅内肿瘤是神经系统常见疾病，其死亡率较高。王沛教授认为颅内肿瘤的病机为痰湿结聚、癌毒炽盛、瘀血阻络；临床治疗颅内肿瘤从“痰”“毒”“瘀”三方面治疗，常以藤梨根为基础用药，清热解毒、利湿化痰、活血消肿，根据病情轻重，灵活调整藤梨根的用量，配合化痰、攻毒、散瘀药物，并注重脾肾在提升肿瘤患者正气中的作用，取得较好的临床效果。

Abstract

关键词

颅内肿瘤藤梨根痰毒瘀

Keywords

references

吴徐超,朱国华,李彦东,等.新疆单中心4645例成人颅内肿瘤流行病学分析[J].中国神经精神疾病杂志,2022,48(10):577-581.

杨柳,王蒙,赵培超,等.颅脑肿瘤患者的预后影响因素分析[J].中国实用神经疾病杂志,2020,23(10):876-879.

CHICA J, YEPES I, BURKS SS, et al. Case of an intracranial malignant peripheral nerve sheath tumor in the setting of pacer-dependent heart block[J]. Asian J Neurosurg, 2018,13(1):147-149.

花宝金.中医药防治肿瘤概述及展望[J].北京中医药,2018,37(12):1103-1106.

王晓戎,黄禹舒,陈仁杰,等.藤梨根乙醇提取物通过AKT/PUMA通路诱导结直肠癌细胞凋亡[J].南京中医药大学学报,2023,39(6):532-540.

杨子华,杨斐然,张薇.中药藤梨根有效成分及其抗肿瘤作用研究进展[J].中华中医药学刊,2021,39(6):204-208.

陈方超,高守红,王志鹏,等.基于UHPLC-Q-TOF-MS/MS技术鉴定藤梨根的化学成分[J].中国药房,2020,31(14):1725-1731.

孟鑫,鲁金月,张爱琳,等.藤梨根抗肿瘤药效物质和药理活性研究进展[J].实用肿瘤学杂志,2022,36(1):69-73.

陈纯辉,孙学刚,魏素芬,等.肿瘤微环境血瘀病机探讨[J].中西医结合研究,2023,15(3):195-197,201.

沈金阳,张烜,于媛媛,等.海藻多肽的提取分离及抗肿瘤活性研究进展[J].河北大学学报(自然科学版),2023,43(4):379-386.

姜秋,王玲娜,刘燕,等.僵蚕的炮制历史沿革、化学成分及药理作用研究进展[J].中国中药杂志,2023,48(12):3269-3280.

夏子昊,赵光利,肖翔文,等.中药蜈蚣的研究进展[J].中药与临床,2023,14(1):103-108.

王艳丽,宁宇,丁莹.地龙的化学成分及药理作用研究进展[J].中医药信息,2022,39(12):86-89.

童长忆,袁芝琼.蜂房的成分和药理作用研究概况[J].云南中医中药杂志,2022,43(2):91-95.

喻昌燕,孟令杰,姜念,等.蟾皮化学成分和药理活性的研究进展[J].中草药,2021,52(4):1206-1220.

范东伟,廖姣姣,冯玉婷,等.马钱子及其活性成分临床应用研究进展[J].科技导报,2023,41(3):37-43.

王郅宜,李泉旺,林事成,等.中医护场理论在肿瘤治疗中的应用[J].北京中医药,2024,43(4):417-420.

张莉莉,杨浩宇,郝瑞,等.仙茅、淫羊藿、枸杞子改善老年免疫力低下、机能减退经验：仝小林三味小方撷萃[J].吉林中医药,2020,40(8):989-991.

刘洋,杜婧,沈颜红.10种药用黄芪属植物化学成分及药理作用的研究进展[J].中国实验方剂学杂志,2017,23(18):222-234.

毛艺,刘苓霜,沈丽萍.肿瘤血瘀证及活血化瘀治疗肿瘤研究进展[J].河北中医,2022,44(11):1926-1931,1936.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

QIN Bowei's experience in differentiating and treating liver cirrhosis from the perspective of "deficiency, depression, stasis, and water"

LI Yuanwen's experience in treating skin diseases with insect drugs based on the theory of “wind, toxin, and collaterals”

Analysis of LI Guoqin's experience in treating phlegm

Experience in treating drug eruption from the perspective of "dampness, toxin and heat"

Discussion and development of Danggui Shaoyao Powder in the treatment of chronic prostatitis

Related Author

LIU De

SUN Chenyang

LIU Tong

LUO Changyong

ZENG Yanpeng

CHEN Yifan

LI Yan

SUN Lingling

Related Institution

北京中医药大学东直门医院急诊科

北京中医药大学国学院

北京中医药大学东方医院感染科

北京中医药大学东方医院皮肤科

中国中医科学院广安门医院南区呼吸科

⁰

WANG Pei's experience in treating intracranial tumors from phlegm, toxin, and stasis by using Actinidia roots

DOI：10.16025/j.1674-1307.2025.01.016

摘要

Abstract

关键词

Keywords

references